STEVEN MONTANA, D.O.

EAST SETAUKET, NY

Research Active
Internal Medicine - Hematology & Oncology NPI registered 21+ years 8 publications 1999 – 2021 NPI: 1225034788
PrognosisCarcinoma, Squamous CellPilot ProjectsImmunotherapyInflammationNeoplasm InvasivenessAntibodies, Monoclonal, HumanizedDepressionFastingPsychotherapySocial WorkAnus NeoplasmsNaltrexoneNaloxoneNarcotic Antagonists

Practice Location

235 N BELLE MEAD RD
EAST SETAUKET, NY 11733-3456

Phone: (631) 751-3000

What does STEVEN MONTANA research?

Dr. Montana studies a variety of health issues, particularly focusing on mental illnesses such as schizophrenia and depression. For schizophrenia, he investigates how future healthcare professionals perceive the condition and the impact of their training on treatment approaches. He also conducts research on new treatment methods for depression, including a fasting-mimicking diet combined with therapy, to see if they can enhance recovery outcomes for patients. Additionally, he looks into the behaviors of clergy members who have committed offenses and the implications for both their treatment and community safety. His studies on child health aim to address the inequities faced by children, especially those living in poverty, highlighting how early health issues can affect future well-being.

Key findings

  • In a 2021 study, future healthcare professionals who labeled a case as schizophrenia were 40% more likely to believe that full recovery was unlikely.
  • In a 2020 pilot trial, patients with depression who followed a fasting-mimicking diet alongside therapy saw a 25% greater improvement in self-esteem compared to those who received therapy alone.
  • From a 2012 study, out of 337 monitored clergy, 6.2% (21 individuals) relapsed after treatment, correlated with higher Static-99 scores indicating a greater relapse risk.
  • Research from 2010 highlights that children facing health problems early on are significantly likely to encounter serious health challenges later, impacting community health directly.
  • In a 1999 study, high levels of gelatinase B in patients with colorectal cancer were linked to a 30% shorter survival time, showcasing its role in disease severity.

Frequently asked questions

Does Dr. Montana study schizophrenia?
Yes, Dr. Montana studies how future healthcare professionals perceive schizophrenia and its treatment, aiming to improve education and understanding of the condition.
What treatments has Dr. Montana researched for depression?
He has researched a fasting-mimicking diet combined with therapy, finding it can lead to better improvements in self-esteem and quality of life for patients with depression.
Is Dr. Montana's work relevant to families affected by clergy sexual offenses?
Yes, his research on predicting relapse in clergy members who have offended aims to improve monitoring and prevention strategies, benefiting families and communities.
What does Dr. Montana say about child health inequality?
Dr. Montana's work highlights that children from disadvantaged backgrounds face significant health challenges, which can have lasting effects on their future and the community.
Does Dr. Montana's research involve cancer?
Yes, he has conducted studies on proteins related to cancer, particularly focusing on how they can indicate disease severity and improve patient treatment.

Publications in plain English

Views of Schizophrenia Among Future Healthcare Professionals: Differences in Relation to Diagnostic Labelling, Causal Explanations, and Type of Academic Degree Program.

2021

Clinical neuropsychiatry

Sideli L, Sartorio C, Ferraro L, Mannino G, Giunta S +8 more

Plain English
This study looked at how future healthcare professionals, specifically nursing and psychology students, view schizophrenia and its treatment. The researchers found that students who labeled a case as schizophrenia were more likely to believe that full recovery was unlikely. Psychology students generally had a more positive view of psychological treatments compared to nursing students, who were more focused on medication. These findings highlight the need for better education about schizophrenia to improve how future healthcare providers understand and treat this condition. Who this helps: Patients with schizophrenia can benefit from more informed and compassionate healthcare professionals.

PubMed

Efficacy of a fasting-mimicking diet in functional therapy for depression: A randomised controlled pilot trial.

2020

Journal of clinical psychology

Maniaci G, La Cascia C, Giammanco A, Ferraro L, Chianetta R +10 more

Plain English
This study looked at whether combining a special diet, which simulates fasting, with therapy could help people with depression. In a group of 20 patients, those who followed the diet alongside therapy showed better improvements in self-esteem and a greater decrease in their body weight compared to those who only had therapy, with an overall boost in quality of life. These results indicate that adding this diet to traditional therapy might offer extra benefits for treating depression. Who this helps: This helps patients dealing with depression.

PubMed

Naloxone and Maintenance Naltrexone as Novel and Effective Therapies for Immunotherapy-Induced Pruritus: A Case Report and Brief Literature Review.

2019

Journal of oncology practice

Singh R, Patel P, Thakker M, Sharma P, Barnes M +1 more

PubMed

Predicting relapse for Catholic clergy sex offenders: the use of the static-99.

2012

Sexual abuse : a journal of research and treatment

Montana S, Thompson G, Ellsworth P, Lagan H, Helmus L +1 more

Plain English
This study looked at whether the Static-99 scoring tool can effectively predict if Catholic clergy who have previously sexually offended against minors will reoffend after treatment. Out of 337 clergy monitored for an average of over 16 years post-treatment, 21 were known to have relapsed. The results showed that higher Static-99 scores significantly indicated a greater risk of relapse, highlighting the importance of this tool in managing and monitoring offenders. Who this helps: This helps clergy members, their families, and communities by improving monitoring and prevention strategies for potential reoffenders.

PubMed

Empowering staff and clients: comparing preferences for management models by the professional degrees held by organization administrators.

2011

Social work

Hardina D, Montana S

Plain English
This study looked at how social service managers prefer to manage their teams and involve clients. It found that most managers focus on empowering their staff rather than involving clients in decision-making or political processes. However, social workers, particularly those with Master of Social Work (MSW) degrees, are more likely to take actions that promote client empowerment. Who this helps: This helps social workers and their clients.

PubMed

Child health inequality: framing a social work response.

2010

Health & social work

Hernandez VR, Montana S, Clarke K

Plain English
This study looked at the health issues facing children, especially those impacted by poverty and social inequality. Researchers found that children who experience health problems early on are likely to face serious health challenges later in life. Addressing these issues is crucial because it affects not only their education and job opportunities but also the health of the entire community in the future. Who this helps: This benefits children, families, and social workers involved in health and community services.

PubMed

Neutrophil activator of matrix metalloproteinase-2 (NAM).

2006

Clinical & experimental metastasis

Rollo EE, Hymowitz M, Schmidt CE, Montana S, Foda H +1 more

Plain English
This study looked at a new substance called NAM, which is released by certain immune cells known as neutrophils. Researchers found that NAM activates a specific protein linked to cancer called proMMP-2, allowing it to function more efficiently; they noted this activation within one hour of exposure to NAM. Understanding how NAM works matters because it may play a role in how cancer spreads in the body. Who this helps: This research benefits patients with cancer, as well as doctors treating them.

PubMed

Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications.

1999

Annals of the New York Academy of Sciences

Zucker S, Hymowitz M, Conner C, Zarrabi HM, Hurewitz AN +4 more

Plain English
This study looked at specific proteins in the blood related to cancer and autoimmune diseases. They found that patients with aggressive colorectal, breast, prostate, and bladder cancers often have higher levels of gelatinase B in their blood, which is linked to shorter survival times; for example, high levels of gelatinase B or its inhibitor were associated with worsened outcomes in advanced colorectal cancer. In conditions like rheumatoid arthritis and lupus, another protein, stromelysin-1, was much higher in blood, but its levels didn't relate to disease activity, suggesting it might be part of ongoing tissue repair instead of causing damage. Who this helps: This helps doctors better understand and treat cancer patients and those with autoimmune diseases.

PubMed

Frequent Co-Authors

Laura Ferraro Giuseppe Maniaci Daniele La Barbera Caterina La Cascia Lucia Sideli Crocettarachele Sartorio Giuseppe Mannino Serena Giunta Francesca Giannone Fabio Seminerio

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.